These two ASX-listed stocks failed our corporate BS test

Who will it be in the August reporting period?
Marcus Howes

Plato Investment Management

In May 2018, Elon Musk hosted what several analysts called one of the strangest earnings calls they had ever heard. Partway through Tesla’s first-quarter call, he cut off a Bernstein analyst with “boring, bonehead questions are not cool,” handed the floor to a retail investor on YouTube, and told the market to “please sell our stock.”

Asked about Tesla’s moat, he said “moats are lame.”

The quarterly loss was narrower than Wall Street feared. The stock fell more than 5 per cent anyway. What spooked the market was not the loss. It was the dodging.

This is an extreme example - you didn’t need an algorithm to work it out. The trouble is most executives are well-trained in the art of evasion.

With ASX reporting season almost here, it’s a good time to highlight one of Plato’s red flag tools that we’ll be monitoring closely as earnings call transcripts are released. 

Teaching a machine to listen

Over the past 3 years, our quantitative analytics team has been refining what in its simplest form can be described as a corporate BS detector. Using Natural Language Processing (NLP), our proprietary systems are now adept at detecting evasion during earnings calls.

We ingest every available earnings call, isolating the unscripted Q&A segment, where prepared remarks give way to live Q&A. From every response, language vectors are extracted to detect the following three factors.

  • Q&A divergence (is the response to the question off topic)
  • Length of answer to question ratio (where a simple question gets a long-winded answer)
  • High proportion of forward-tense in answers 

The first of these is where large language models, the same kind of AI behind today’s chatbots, do the work: we use them to measure how closely each answer stays on topic with the question asked. All three measures capture whether management is engaging with what it is being asked or simply managing the room.

If all three of the above signals fire, a composite red flag is activated.

For those unfamiliar with our red flags risk management framework, we find companies with 8 or more red flags underperform the market by around 20% over the proceeding 12-month period.

The system now includes over 150 red flags ranging from this language detector, to accounting practices, executive backgrounds, balance sheet items, and social and governance factors.

NPL case studies

Wind back to ResMed’s April 2023 earnings call. Revenue up 29 per cent, device sales up more than 40 per cent. The market loved it on the day.

Near the end, a Goldman Sachs analyst asked a short and direct question that mattered: could weight-loss drugs like Ozempic shrink ResMed’s market?

The answer ran to roughly 470 words. It opened by recasting the threat as “a huge market and actually quite exciting.” It detoured through a 23-year-old anecdote about bariatric surgery, then promised that “we’re going to partner with pharma in this space.”

What it never did was answer the question: could the addressable market shrink?

A seven-to-one answer-to-question ratio, three pivots into the future tense, and the core of the question left unanswered. It wasn’t a one-off: a profit margin query drew four “I’m bullish” responses, but no timeframe.

Plato
Plato

Plato was underweight ResMed at the time. On top of six other red flags, run our evasion signal over this call, and it lights up on its own.

On 8 August 2023, Novo Nordisk released the headline results of its SELECT trial: semaglutide, sold as Wegovy, cut major cardiovascular events by 20 per cent. The GLP-1 story was no longer only about weight loss. ResMed shares, already sliding, fell by around a third.

The April numbers were excellent, but the non-answer was the tell.

Notably, the stock recovered over the following year as the GLP-1 fears proved overstated, and it remains a successful, well-run company today. But in this case, the signal flagged the incoming shorter-term sentiment shift that would surround the company.

More recently in February, Smart Parking (ASX: SPZ) reported a record half: revenue up 96%, EBITDA up 85%. Yet almost every question circled the same doubt: how much of it was real?

It leaned on an acquisition and a one-off-looking surge in debt recovery, while underlying UK volumes were flat, and profit margins slipped.

Asked about reputational risk, a looming UK price cap, and the quality of its debt book, the CEO reframed each rather than answering. Our signal flagged the call, and evasion was one of six red flags which led to a short position in the Plato Global Alpha Fund. The stock fell over 30 per cent in the next three months.

The whole is greater than the sum of the parts

None of this is about catching anyone in a lie. Companies evade for ordinary reasons: they don’t know, they can’t say, they’d rather change the subject. But evasion is information, and it clusters around exactly the questions that matter most.

A person listening live forgives a confident dodge. A systematic process does not: it scores every exchange the same way, with no charisma in the room and no benefit of the doubt.

It’s important to emphasise questions evasion alone doesn’t mean a company is a bad investment – there are many variables to consider when it comes to why question evasion might be flagged. 

However, when it corresponds with numerous other red flags, the whole is much greater than the sum of the parts.

Invest with Plato Investment Management

The Plato Global Alpha Fund is a long/short global equities strategy that has delivered +24.5% p.a. after fees since inception (1 Sept 2021). 

The fund is accessible on the ASX via the Plato Global Alpha Complex ETF (ASX: PGA1).

Managed Fund
Plato Global Alpha Fund
Global Shares
ETF
Plato Global Alpha Complex ETF (PGA1)
Global Shares
Managed Fund
Plato Global Shares Income Fund
Global Shares
Managed Fund
Plato Australian Shares Income Fund
Australian Shares
LIC
Plato Income Maximiser (PL8)
Australian Shares
........
This communication is prepared by Plato Investment Management Limited (‘Plato’) (ABN 77 120 730 136, AFSL 504616). Pinnacle Fund Services Limited (‘PFSL’) (ABN 29 082 494 362, AFSL 238371) is the product issuer of Plato Funds. PFSL is not licensed to provide financial product advice. PFSL is a wholly-owned subsidiary of the Pinnacle Investment Management Group Limited (‘Pinnacle’) (ABN 22 100 325 184). The Product Disclosure Statement (‘PDS’) and Target Market Determination (‘TMD’) of the Fund are available via the links below. Any potential investor should consider the PDS and TMD before deciding whether to acquire, or continue to hold units in, the Fund. Link to the Product Disclosure Statement Link to the Target Market Determination For historic TMD’s please contact Pinnacle client service Phone 1300 010 311 or Email [email protected] This communication is for general information only. It is not intended as a securities recommendation or statement of opinion intended to influence a person or persons in making a decision in relation to investment. It has been prepared without taking account of any person’s objectives, financial situation or needs. Any persons relying on this information should obtain professional advice before doing so. Past performance is for illustrative purposes only and is not indicative of future performance. Whilst Plato, PFSL and Pinnacle believe the information contained in this communication is reliable, no warranty is given as to its accuracy, reliability or completeness and persons relying on this information do so at their own risk. Subject to any liability which cannot be excluded under the relevant laws, Plato, PFSL and Pinnacle disclaim all liability to any person relying on the information contained in this communication in respect of any loss or damage (including consequential loss or damage), however caused, which may be suffered or arise directly or indirectly in respect of such information. This disclaimer extends to any entity that may distribute this communication. Any opinions and forecasts reflect the judgment and assumptions of Plato and its representatives on the basis of information available as at the date of publication and may later change without notice. Any projections contained in this presentation are estimates only and may not be realised in the future. Unauthorised use, copying, distribution, replication, posting, transmitting, publication, display, or reproduction in whole or in part of the information contained in this communication is prohibited without obtaining prior written permission from Plato. Pinnacle and its associates may have interests in financial products and may receive fees from companies referred to during this communication.

Marcus Howes
Quantitative Research Analyst
Plato Investment Management

Marcus joined Plato in early 2023. With a practical understanding of machine learning and neural networks, Marcus specialises in leveraging Natural Language Processing (NLP) techniques and harnessing the capabilities of Large Language Models...

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.

Comments

Sign In or Join Free to comment
The 10th annual Livewire Live 2026

One room. One day. The minds that move markets.

22 September 2026 Art Gallery of NSW, Sydney

Register Now